Skip to contentS
Skinvisible, Inc.
S
SKVISkinvisible, Inc. Q3 2025 · 10-Q
Revenue$5.00K$5.00K±0.0% vs Q3 2024 Net Income-$250.25K-$250.25KN/M vs Q3 2024 EPS, diluted—
Operating Income-$106,057N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skinvisible, Inc. · CIK 1085277 · Engraved from SEC EDGAR
Operating Cash Flowderived$524N/M Free Cash Flowderived$525N/M Margins · derivedGross margin100.0%±0.0 pt vs Q3 2024
Operating margin-2121.1%+378.2 pt vs Q3 2024
Net margin-5004.9%+727.2 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 13, 2025 · 44 d after period end